Notifications
Back
Notification settings
Back
More
Post notifications
Post reactions
Be notified when someone leaves a comment or a reply to your post or comment.
Updates and news
Stay ahead of important updates and news from the site.
  • Alarm
    Edit profile information
  • My account Sign out
  • About us
    • Vision
    • People
    • Contact
  • Platform
    • NNP Design AI™
    • NNP Manufacturing™
    • Publication
  • Pipeline
  • CSO
  • News
    • Notice
    • Press Release
SHIFTBIO INC.
  • About us
  • Platform
  • Pipeline
  • CSO
  • News
Five-set® Five-set® Five-set®
  • About us
    • Vision
    • People
    • Contact
  • Platform
    • NNP Design AI™
    • NNP Manufacturing™
    • Publication
  • Pipeline
  • CSO
  • News
    • Notice
    • Press Release
MENU
About us
  • Vision
  • People
  • Contact
Platform
  • NNP Design AI™
  • NNP Manufacturing™
  • Publication
Pipeline
CSO
News
  • Notice
  • Press Release
icon
Five-set® Five-set® Five-set®
  • About us
    • Vision
    • People
    • Contact
  • Platform
    • NNP Design AI™
    • NNP Manufacturing™
    • Publication
  • Pipeline
  • CSO
  • News
    • Notice
    • Press Release
MENU
About us
  • Vision
  • People
  • Contact
Platform
  • NNP Design AI™
  • NNP Manufacturing™
  • Publication
Pipeline
CSO
News
  • Notice
  • Press Release
icon
MENU
SHIFTBIO INC. SHIFTBIO INC. SHIFTBIO INC.
icon

Platform

Publication

  • NNP Design AI™
  • NNP Manufacturing™
  • Publication
  • NNP Design AI™
  • NNP Manufacturing™
  • Publication

Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα-extracellular vesicles for treating acute liver failure


Nature Communications
Impact Factor: 14.7
Feb 2025

view detail

Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα-extracellular vesicles for treating acute liver failure
Nature Communications
Impact Factor: 14.7
Feb 2025

view detail

Controlled delivery of HIF-1α via extracellular vesicles with collagen-binding activity for enhanced wound healing


Journal of Controlled Release
Impact Factor: 10.5
Apr 2025

view detail

Controlled delivery of HIF-1α via extracellular vesicles with collagen-binding activity for enhanced wound healing
Journal of Controlled Release
Impact Factor: 10.5
Apr 2025

view detail

Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity


Advanced Science
Impact Factor: 14.3
April 2024

view detail

Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity
Advanced Science
Impact Factor: 14.3
April 2024

view detail

Harnessing Oncolytic Extracellular Vesicles for Tumor Cell-Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy.


Small
Impact Factor: 13.7
May 2023

view detail

Harnessing Oncolytic Extracellular Vesicles for Tumor Cell-Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy.
Small
Impact Factor: 13.7
May 2023

view detail

Small Extracellular Vesicles as a New Class of Medicines


Pharmaceutics
Impact Factor: 4.9
Jan 2023

view detail

Small Extracellular Vesicles as a New Class of Medicines
Pharmaceutics
Impact Factor: 4.9
Jan 2023

view detail

Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy.


Journal of Controlled Release
Impact Factor: 10.5
Nov 2022

view detail

Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy.
Journal of Controlled Release
Impact Factor: 10.5
Nov 2022

view detail

Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy


Advanced Materials
Impact Factor: 30.2
Dec 2020

view detail

Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy
Advanced Materials
Impact Factor: 30.2
Dec 2020

view detail

Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity


Science Advances
Impact Factor: 11.7
Jul 2020

view detail

Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity
Science Advances
Impact Factor: 11.7
Jul 2020

view detail

Functionalized exosome harboring bioactive molecules for cancer therapy


Cancer Letters
Impact Factor: 9.1
Oct 2020

view detail

Functionalized exosome harboring bioactive molecules for cancer therapy
Cancer Letters
Impact Factor: 9.1
Oct 2020

view detail

Intrinsic cancer vaccination


Advanced Drug Delivery Reviews
Impact Factor: 15.2
Nov 2019

view detail

Intrinsic cancer vaccination
Advanced Drug Delivery Reviews
Impact Factor: 15.2
Nov 2019

view detail

Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery


Journal of Extracellular Vesicles
Impact Factor: 15.5
Dec 2018

view detail

Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery
Journal of Extracellular Vesicles
Impact Factor: 15.5
Dec 2018

view detail

Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer


Advanced Materials
Impact Factor: 30.2
Mar 2018

view detail

Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer
Advanced Materials
Impact Factor: 30.2
Mar 2018

view detail

Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis


Biomaterials
Impact Factor: 12.8
Mar 2017

view detail

Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis
Biomaterials
Impact Factor: 12.8
Mar 2017

view detail

Virus‐mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes


Advanced Materials
Impact Factor: 30.2
Mar 2017

view detail

Virus‐mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes
Advanced Materials
Impact Factor: 30.2
Mar 2017

view detail

More


1st floor, 76 Hwarang-ro, 

Seongbuk-gu, Seoul, Republic of Korea 

contact@shiftbio.net
Tel: 02-942-1109 

Copyright ⓒ 2025 SHIFTBIO INC. All rights reserved.